CMS has advised Werfen on its approximately USD 25 million acquisition of Omixon Biocomputing. Hogan Lovells advised Omixon.
Werfen is a Barcelona-based healthcare company.
Omixon Biocomputing is a transplant diagnostics company headquartered in Budapest.
The CMS team included Partner Aniko Kircsi, Senior Counsels Peter Toth and Gyorgy Balint, and Associates Orsolya Pass and Gergely Torma.
The Hogan Lovells team included Partner Sandor Bekesi and Senior Associate Gabor Koszo.
